Skip to search formSkip to main contentSkip to account menu

milameline

Known as: 1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxaldehyde O-methyloxime monohydrochloride 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Prepulse inhibition (PPI) of the acoustic startle reflex is a sensorimotor gating process known to be deficient in a number of… 
Highly Cited
2003
Highly Cited
2003
Objective: To assess the feasibility of using MRI measurements as a surrogate endpoint for disease progression in a therapeutic… 
Highly Cited
2000
Highly Cited
2000
OBJECTIVE: To test the interrater reliability of the Clinical Dementia Rating (CDR) in a multicenter clinical trial. 
Review
1999
Review
1999
Alzheimer’s Disease (AD) is the most common single cause of dementia in our ageing society. Traditionally thought of as an… 
Highly Cited
1999
Highly Cited
1999
The purpose of our studies was to determine the effects of muscarinic receptor agonists on conditioned avoidance responding in… 
1999
1999
Abstract  Rationale: Cholinomimetic therapy in Alzheimer’s disease (AD) has been hampered by narrow efficacious dose ranges and… 
1999
1999
Research into and development of selective muscarinic receptor agonists for the treatment of Alzheimer’s disease is based on the…